Global Vaccine Market Forecast to 2012

The prevalence of infectious and non-infectious diseases has significantly risen worldwide, leading to a spur in healthcare expenditure of both the developed and developing countries. Vaccine represents one of the most attractive and fast growing sectors, with players’ revenue exceeding their expectations. Apart from the high disease prevalence, growing population and emergence of new pandemics are important growth drivers of the global vaccine market.

According to our new research report “Global Vaccine Market Forecast to 2012”, the market for adult vaccines has been growing at faster rate than pediatric vaccines. The rising prevalence of life threatening diseases such as cancer and HIV is the prominent factor driving growth in the adult vaccine segment. A number of healthcare companies are focusing on cancer vaccine development process so that they can enhance their profit. The cancer vaccine market is expected to grow at a CAGR of 25% during 2009-2012 on the back of government support and rising participation of private players.

Our analysis of the global vaccine market with emphasis on the country level illustrates that the fast developing countries such as India and China will raise their overall share. Currently, these countries have been actively participating in market activities and vaccine manufacturers are booking profits on their sales. Besides, other countries will facilitate the development of vaccine market in their respective places in order to minimize health problems.

The report is an outcome of extensive research and objective analysis of the vaccine market in key countries of the world. It identifies all the necessary factors and aspects related to market and represent current industry status with future forecast on vaccine types and countries for 2009-2012. In addition, the description of key players and their recent activities have been provided to showcase an effective and balanced outlook of the global vaccine market.